Breakthrough in Cancer Treatment with NK Cells from Stem Cells

Scientists in China have introduced a new approach to producing natural killer (NK) cells using stem cells for cancer treatment. By employing CD34+ hematopoietic stem cells from cord blood, the team generated large quantities of induced NK and CAR-engineered NK cells. This method offers improved efficiency compared to traditional techniques relying on mature NK cells. The research, published in Nature Biomedical Engineering, highlights significant reductions in cost and processing time, while also boosting cell output. Lab experiments demonstrated strong tumor inhibition in leukemia models.